Therapy of the Overactive Bladder Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

March 31, 2015

Conditions
Overactive Bladder
Interventions
DRUG

solifenacin

solifenacin 5mg tablet once daily

PROCEDURE

PFMT and WBVT

pelvic floor muscle and whole body vibration training once a week

Trial Locations (1)

8501

Blasenzentrum, Cantonal Hospital, Frauenfeld

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Astellas Pharma Inc

INDUSTRY

lead

Cantonal Hospital, Frauenfeld

OTHER